Lexaria Bioscience (LEXXW) Competitors $0.22 -0.01 (-4.39%) As of 06/13/2025 10:25 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock LEXXW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUWShould you be buying Lexaria Bioscience stock or one of its competitors? The main competitors of Lexaria Bioscience include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry. Lexaria Bioscience vs. Its Competitors 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Atlantic Coastal Acquisition Corp. II Biofrontera biote BriaCell Therapeutics Celularity Lexaria Bioscience (NASDAQ:LEXXW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, earnings, profitability, valuation, risk, institutional ownership, community ranking and dividends. Does the MarketBeat Community prefer LEXXW or ATNFW? Lexaria Bioscience and 180 Life Sciences both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformLexaria BioscienceN/AN/A180 Life SciencesN/AN/A Is LEXXW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets Lexaria BioscienceN/A N/A N/A 180 Life Sciences N/A N/A N/A Does the media favor LEXXW or ATNFW? In the previous week, Lexaria Bioscience had 1 more articles in the media than 180 Life Sciences. MarketBeat recorded 2 mentions for Lexaria Bioscience and 1 mentions for 180 Life Sciences. 180 Life Sciences' average media sentiment score of 1.87 beat Lexaria Bioscience's score of 0.44 indicating that 180 Life Sciences is being referred to more favorably in the news media. Company Overall Sentiment Lexaria Bioscience Neutral 180 Life Sciences Very Positive Which has stronger earnings & valuation, LEXXW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLexaria Bioscience$525.92KN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A SummaryLexaria Bioscience beats 180 Life Sciences on 2 of the 3 factors compared between the two stocks. Get Lexaria Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for LEXXW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LEXXW vs. The Competition Export to ExcelMetricLexaria BioscienceBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$126.08M$5.57B$8.51BDividend YieldN/A3.74%5.27%4.15%P/E RatioN/A3.2526.7819.65Price / SalesN/A4,108.15404.49152.18Price / CashN/A13.1938.2534.64Price / BookN/A35.866.964.59Net IncomeN/A-$91.56M$3.23B$248.23M7 Day PerformanceN/A0.31%-1.24%-1.07%1 Month Performance27.33%6.18%8.34%3.35%1 Year Performance-84.07%178.38%33.30%13.77% Lexaria Bioscience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LEXXWLexaria BioscienceN/A$0.22-4.4%N/A-84.1%$0.00$525.92K0.007Short Interest ↑Gap DownATNFW180 Life SciencesN/A$0.01-3.1%N/A-38.0%$0.00N/A0.007Gap DownLBPSW4D pharmaN/AN/AN/AN/A$0.00$522K0.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.01+4.5%N/AN/A$0.00N/A0.002Gap UpHigh Trading VolumeAIMDWAinosN/A$0.16+6.9%N/A+118.3%$0.00$106.21K0.0040ALVOWAlvotechN/A$2.41-3.6%N/A-41.6%$0.00$585.60M0.004News CoverageACABWAtlantic Coastal Acquisition Corp. IIN/A$0.02+27.7%N/AN/A$0.00N/A0.0015Gap UpBFRIWBiofronteraN/A$0.14+49.5%N/A+136.9%$0.00$38.00M0.0070BTMDWbioteN/A$0.03+26.7%N/A-94.4%$0.00$199.38M0.00N/AGap DownBCTXWBriaCell TherapeuticsN/A$0.09-12.6%N/A-80.0%$0.00N/A0.008Short Interest ↑CELUWCelularityN/A$0.05+25.0%N/A+118.3%$0.00$54.22M0.00220Gap Down Related Companies and Tools Related Companies 180 Life Sciences Alternatives 4D pharma Alternatives Aesther Healthcare Acquisition Alternatives Ainos Alternatives Alvotech Alternatives Atlantic Coastal Acquisition Corp. II Alternatives Biofrontera Alternatives biote Alternatives BriaCell Therapeutics Alternatives Celularity Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LEXXW) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredOil Hits $74 - $100 Next?Oil Jumps 8.5% on Middle East Crisis Trump at Oil Fields Oil surged 8.5% to $74/barrel after Israel's Ir...The Oxford Club | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredAs Bitcoin supply vanishes, this Trump-aligned token could explodeBitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lexaria Bioscience Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lexaria Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LEXXW Stock Free LEXXW Stock Alerts